EFFECTOR THERAPEUTICS INC - 28202V108
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q4 2023
· Q3 2023
Value (USD)
Total reported value ($000)
$8.492M
QoQ value delta ($000)
+$3.27M
(+62.62%)
Implied price effect (QoQ)
+50.22%
Shares
Total shares
9,480,168
QoQ shares delta
+722,933
(+8.26%)
Total shares held by funds (by quarter)
Top holders (Q4 2023)
Top 25 only
Full list
Early Q3 2024 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 4,264 | 364,934 | 0.03% |
| Carlyle Group Inc. | 2,228 | 4,822,114 | 0.11% |
| Parallel Advisors, LLC | 791 | 1,693,559 | 0.02% |
| Blackstone Inc. | 611 | 1,308,587 | 0.0% |
| VANGUARD GROUP INC | 268 | 574,413 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 190 | 407,974 | 0.0% |
| NORTHERN TRUST CORP | 75 | 160,812 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22 | 48,600 | 0.0% |
| STATE STREET CORP | 14 | 30,885 | 0.0% |
| STIFEL FINANCIAL CORP | 10 | 22,660 | 0.0% |
| MORGAN STANLEY | 8 | 18,000 | 0.0% |
| Vontobel Holding Ltd. | 7 | 15,000 | 0.0% |
| UBS Group AG | 4 | 9,092 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 68 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 27 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 314 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 145 | 0.0% |
| SIMPLEX TRADING, LLC | 0 | 1,735 | 0.0% |
| Tower Research Capital LLC (TRC) | 0 | 1,168 | 0.0% |
| Qube Research & Technologies Ltd | 0 | 81 | 0.0% |